Literature DB >> 23849173

Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy.

Alexandra Quinn1, Lois Holloway, Nicholas Hardcastle, Wolfgang A Tomé, Anatoly Rosenfeld, Peter Metcalfe.   

Abstract

This study investigates the dose from the 1mm collimator width megavoltage fan-beam CT (fine, normal and coarse pitch) available on tomotherapy as well as for whole-breast tomotherapy treatments. The BEIR VII lifetime attributable risk model was utilised to assess the significance of the imaging dose relative to the treatment dose.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast; Cancer risk; Dose; Megavoltage CT; Tomotherapy

Mesh：

Year:  2013        PMID： 23849173     DOI： 10.1016/j.radonc.2013.05.019

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  2 in total

1.  Assessment of leakage dose in vivo in patients undergoing radiotherapy for breast cancer.

Authors:  Peta Lonski; Tomas Kron; Michael Taylor; Alicia Phipps; Rick Franich; Boon Chua
Journal:  Phys Imaging Radiat Oncol       Date:  2018-03-26

2.  Imaging dose in breast radiotherapy: does breast size affect the dose to the organs at risk and the risk of secondary cancer to the contralateral breast?

Authors:  Vikneswary Batumalai; Alexandra Quinn; Michael Jameson; Geoff Delaney; Lois Holloway
Journal:  J Med Radiat Sci       Date:  2015-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.